| Popis: |
Summary. We studied 261 patients with newly detected MDR tuberculosis who were divided into 2 groups. The first group consisted of 164 patients in whom, before hospitalization determined the resistance of M. tuberculosis to rifampicin by the GeneXpert MTB/RIF method. Treatment of this group of patients was initially conducted according to the 4th regimen of chemotherapy (pyrazinamide, kanamycin/amk/capreomycin, fluoroquinolone, cycloserine/terizidone, protionamide, PAS). The second group (the comparison group) included 97 patients in whom MDR was diagnosed by sputum culture method. Prior to receiving data on the drug resistance, these patients were received treatment according to the 1st standard chemotherapy regimen (isoniazid, rifampicin, pyrazinamide, ethambutol). After detecting MDR M. tuberculosis (after 2-3 months of treatment) correction treatment with re-registration for 4th regimens were performed. It was found that the new detected MDR tuberculosis in the Stavropol region of Russian Federation is more often detected in men in the form of infiltrative tuberculosis, characterized by the M. tuberculosis positive sputum and destruction in lung tissue up to 2 cm in size. The efficacy of treatment by conversation sputum culture after 3 and 6 months of treatment, as well as to close cavities after 6 months of treatment in the group of patients initially treated with 4 regimens of chemotherapy was significantly high in comparison with patients initially treated with 1 and then 4 chemotherapy regimens.
№8(163) (2018) |
